logo
Plus   Neg
Share
Email

Sandoz To Appeal U.S. Court Ruling In Biosimilar Erelzi U.S. Patent Case

Sandoz, a Novartis division (NVS), said that the United States District Court of New Jersey ruled against Sandoz in patent litigation regarding the Sandoz biosimilar, Erelzi or etanercept-szzs for reference medicine Enbrel or etanercept. The company will appeal the ruling to the U.S. Court of Appeals for the Federal Circuit, and the parties have agreed to an expedited appeal.

Sandoz said it disagreed with the Court's ruling, which prevents the company from launching an additional treatment option for patients with autoimmune and inflammatory diseases. It continues to consider the patents in this case to be invalid.

According to Sandoz, Amgen asserted two patents that it obtained from Roche, in what Sandoz believes is an attempt to extend its US compound patent protection for etanercept to 2029.oz said, "We will appeal this decision, and look forward to presenting our case to the Federal Circuit and bringing Erelzi to US patients as soon as possible."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google rolled out its Live Caption feature, which was first introduced at its I/O developer conference in May this year. The technology will automatically caption videos and spoken audio on a device, except for phone and video calls. It is helpful when a user is in a loud commuter train, or wants to follow along the conversation more closely. Morgan Stanley (MS) reported Thursday a profit for the third-quarter that increased 2 percent from last year, reflecting higher fixed income revenues. Quarterly revenues also rose 2 percent. Both earnings per share and revenues topped analysts' expectations. Shares of Ericsson were gaining around 8 percent in the morning trading in Sweden after the telecom equipment maker lifted its fiscal 2020 sales outlook driven by a stronger 5G market, despite reporting a loss in its third quarter. Börje Ekholm, President and CEO of Ericsson, said, "The largest market for 5G infrastructure will be China where deployments are expected to start near term."
Follow RTT
>